Many investors are struggling to identify compelling reasons to invest in Pfizer at this juncture, particularly when assessing the company's stock market performance this year.
Our Analysis:
As long as the price is below 39.00, follow the recommendations below:
Time frame: D1
Recommendation: short position
Entry point: 35.39
Take Profit 1: 34.00
Take Profit 2: 31.00
Alternative scenario:
If the level of 39.00 is broken-out, follow the recommendations below:
Risk Warning: Forex and CFD trading carry a high degree of risk. As such they may not be suitable for all investors. Investors should ensure they fully understand the risks associated with CFD trading before deciding to trade. Investors may choose to seek independent advice and should not risk more than they are prepared to lose.
